Invention Grant
- Patent Title: Biomedical and chemical sensing with nanobeam photonic crystal cavities using optical bistability
-
Application No.: US13641897Application Date: 2011-04-20
-
Publication No.: US09772284B2Publication Date: 2017-09-26
- Inventor: Qimin Quan , Marko Loncar , Frank Vollmer
- Applicant: Qimin Quan , Marko Loncar , Frank Vollmer
- Applicant Address: US MA Cambridge
- Assignee: President and Fellows of Harvard College
- Current Assignee: President and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge
- Agency: Sheehan Phinney Bass & Green PA
- Agent Peter A. Nieves
- International Application: PCT/US2011/033251 WO 20110420
- International Announcement: WO2011/133670 WO 20111027
- Main IPC: G01N21/63
- IPC: G01N21/63 ; G01N21/77

Abstract:
A miniature optical biosensor and biosensor array where high sensitivity for detection of biomolecular interaction does not require a fluorescent label. Non-linear frequency-shifts of optical resonators (‘nanobeams’) provide a digital all-or-nothing response to equilibrium binding of a biomarker to surface-immobilized bio-recognition elements, a signal suitable to identify active components in genetic and proteomic circuits, as well as toxic substances. The threshold level for the digital response is adjustable to accommodate for varying receptor affinities. A bistable cavity sensing (BCS) method can be used to track the shift of the resonance induced by the analyte more precisely than the conventional cavity sensing method, where the resolution is limited by the cavity linewidth. BCS method can be used to quantitate the concentration of the analyte, and their binding kinetics, affinities and etc.
Public/Granted literature
- US20130157882A1 Biomedical and Chemical Sensing with Nanobeam Photonic Crystal Cavities Using Optical Bistability Public/Granted day:2013-06-20
Information query